President Trump has signed an executive order that aims to cut drug prices by up to 80%, potentially alleviating the financial burden on many American families struggling with high medication costs.
This article explores the troubling issue of high drug prices in the U.S., highlighting insights from Trump and RFK Jr. about Big Pharma's practices. It discusses the stark price differences with Europe and emphasizes the need for transparency and reform in the pharmaceutical industry to protect consumers.